HAP Trading’s Halozyme HALO Stock Holding History

HAP Trading’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-37,059	Closed	-$495K	–	1044
2017 Q1	$480K	Buy	+37,059	New	+$468K	0.03%	347

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HAP Trading's HALO Position: Q2 2017 in Review

HAP Trading sold out of Halozyme (HALO) in Q2 2017, closing a stake of 37,059 shares — an estimated $495K sold.

HAP Trading first reported a position in HALO in Q1 2017 and held it in 1 quarter. The position peaked at $480K in Q1 2017. 167 funds tracked by Wall St. Rank hold HALO as of Q2 2017.

HAP Trading reported no remaining Halozyme position as of Q2 2017 after selling out during the quarter.
HAP Trading sold 37,059 Halozyme shares in Q2 2017, an estimated $495K.
HAP Trading first reported a position in Halozyme in Q1 2017 and held it in 1 quarter.
HAP Trading's Halozyme position peaked at $480K in Q1 2017.
167 funds tracked by Wall St. Rank held Halozyme as of Q2 2017.

Based on HAP Trading's 13F filing for Q2 2017, filed 10 Aug 2017.